How Fc receptor affinity chromatography correlates with antibody glycosylation and ADCC

contributed by Tosoh | 04/09/2021

Therapeutic antibodies not only specifically bind molecules, but also activate immune responses through interaction of their Fc part with Fc receptors on immune cells. The FcγIIIa receptor is particularly important as it leads to the death of pathogenic cells. The process is referred to as antibody dependent cellular cy totoxicit y (ADCC) and increases with along with affinity to the receptor. This in turn depends on Fc glycosylation.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.